+ |
PAX3-FOXO1 | up-regulates quantity by expression
transcriptional regulation
|
FGFR4 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-251569 |
|
|
Homo sapiens |
|
pmid |
sentence |
25211658 |
Several deregulated signalling pathways enhance cell growth by modulating cell-cycle regulatory factors in RMS. The most frequently affected signalling pathways include the insulin-like growth factor (IGF), fibroblast growth factor (FGF), hepatocyte growth factor, and platelet-derived growth factor. In ARMS, PAX-FOXO1 activates these pathways by transcriptional activation of receptor genes including IGFR1, FGFR4, MET (c-Met), and PDGFRA. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
PAX3-FOXO1 | up-regulates quantity by expression
transcriptional regulation
|
IGF2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-251573 |
|
|
Homo sapiens |
|
pmid |
sentence |
25211658 |
Insulin-like growth factor is required for RMS cell growth and IGF2 is expressed in an autocrine manner by the tumour cells. The IGF2 locus shows a loss of imprinting in both ERMS and ARMS tumours and expression of PAX3-FOXO1 can induce the upregulation of IGF2, thus enhancing the activation of IGF signalling pathway in ARMS |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
PAX3-FOXO1 | up-regulates quantity by expression
transcriptional regulation
|
IGF1R |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-251568 |
|
|
Homo sapiens |
|
pmid |
sentence |
25211658 |
Several deregulated signalling pathways enhance cell growth by modulating cell-cycle regulatory factors in RMS. The most frequently affected signalling pathways include the insulin-like growth factor (IGF), fibroblast growth factor (FGF), hepatocyte growth factor, and platelet-derived growth factor. In ARMS, PAX-FOXO1 activates these pathways by transcriptional activation of receptor genes including IGFR1, FGFR4, MET (c-Met), and PDGFRA. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
PAX3-FOXO1 | up-regulates quantity by expression
transcriptional regulation
|
MET |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-251570 |
|
|
Homo sapiens |
|
pmid |
sentence |
25211658 |
Several deregulated signalling pathways enhance cell growth by modulating cell-cycle regulatory factors in RMS. The most frequently affected signalling pathways include the insulin-like growth factor (IGF), fibroblast growth factor (FGF), hepatocyte growth factor, and platelet-derived growth factor. In ARMS, PAX-FOXO1 activates these pathways by transcriptional activation of receptor genes including IGFR1, FGFR4, MET (c-Met), and PDGFRA. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
PAX3-FOXO1 | up-regulates quantity by expression
transcriptional regulation
|
PDGFA |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-251571 |
|
|
Homo sapiens |
|
pmid |
sentence |
25211658 |
Several deregulated signalling pathways enhance cell growth by modulating cell-cycle regulatory factors in RMS. The most frequently affected signalling pathways include the insulin-like growth factor (IGF), fibroblast growth factor (FGF), hepatocyte growth factor, and platelet-derived growth factor. In ARMS, PAX-FOXO1 activates these pathways by transcriptional activation of receptor genes including IGFR1, FGFR4, MET (c-Met), and PDGFRA. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |